Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-Intensity Statin plus Ezetimibe vs Standard Care in Asymptomatic Patients with Coronary Artery Calcium
KCT0008541Phase 4Recruiting
- Sponsor
- Hanmi Pharmaceutical
- Start
- Jul 2023
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ezetimibe, atorvastatin, rosuvastatin in atherosclerotic disease, coronary arteriosclerosis, hyperlipidemia, sponsored by Hanmi Pharmaceutical. Started Jul 2023; status: recruiting.
02
Drugs
ezetimibeatorvastatinrosuvastatin
03
Conditions
atherosclerotic diseasecoronary arteriosclerosishyperlipidemia
Beyond the preview
Go deeper on KCT0008541.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0008541.